Journal of Oncology
Volume 2010 (2010), Article ID 126295, 9 pages
http://dx.doi.org/10.1155/2010/126295
Review Article
Precursor Lesions of High-Grade Serous Ovarian Carcinoma: Morphological and Molecular Characteristics
1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD 21205, USA
2Division of Gynecologic Pathology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
3Department of Medical Oncology, Johns Hopkins University School of Medicine, Baltimore, MD 21287, USA
Received 18 December 2009; Accepted 14 February 2010
Academic Editor: Tian-Li Wang
Copyright © 2010 Amy L. Gross et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Linked References
- K. R. Cho and M. Shih Ie, “Ovarian cancer,” Annual Review of Pathology, vol. 4, pp. 287–313, 2009. View at Google Scholar
- M. Shih Ie and R. J. Kurman, “Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis,” American Journal of Pathology, vol. 164, no. 5, pp. 1511–1518, 2004. View at Google Scholar · View at Scopus
- R. J. Kurman and M. Shih Ie, “Pathogenesis of ovarian cancer: lessons from morphology and molecular biology and their clinical implications,” International Journal of Gynecological Pathology, vol. 27, no. 2, pp. 151–160, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- H. T. Lynch, M. J. Casey, C. L. Snyder et al., “Hereditary ovarian carcinoma: Heterogeneity, molecular genetics, pathology, and management,” Molecular Oncology, vol. 3, no. 2, pp. 97–137, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- P. A. Shaw, J. R. McLaughlin, R. P. Zweemer et al., “Histopathologic features of genetically determined ovarian cancer,” International Journal of Gynecological Pathology, vol. 21, no. 4, pp. 407–411, 2002. View at Google Scholar · View at Scopus
- L. Dubeau, “The cell of origin of ovarian epithelial tumours,” The Lancet Oncology, vol. 9, no. 12, pp. 1191–1197, 2008. View at Publisher · View at Google Scholar · View at Scopus
- R. T. Marquez, K. A. Baggerly, A. P. Patterson et al., “Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon,” Clinical Cancer Research, vol. 11, no. 17, pp. 6116–6126, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- D. Ford, D. F. Easton, D. T. Bishop, S. A. Narod, and D. E. Goldgar, “Risks of cancer in BRCA1-mutation carriers,” The Lancet, vol. 343, no. 8899, pp. 692–695, 1994. View at Publisher · View at Google Scholar · View at Scopus
- D. F. Easton, D. Ford, D. T. Bishop et al., “Breast and ovarian cancer incidence in BRCA1-mutation carriers,” American Journal of Human Genetics, vol. 56, no. 1, pp. 265–271, 1995. View at Google Scholar · View at Scopus
- “The NCCN Clinical Practice Guidelines in Oncology Genetic/Familial High-Risk Assessment: Breast and Ovarian (Version 1.2009),” National Comprehensive Cancer Network, June 2009, http://www.nccn.org.
- T. R. Rebbeck, H. T. Lynch, S. L. Neuhausen et al., “Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations,” The New England Journal of Medicine, vol. 346, no. 21, pp. 1616–1622, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- G. H. Eltabbakh and M. S. Piver, “Extraovarian primary peritoneal carcinoma,” Oncology, vol. 12, no. 6, pp. 813–819, 1998. View at Google Scholar
- A. Finch, “Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 mutation,” Journal of the American Medical Association, vol. 296, no. 2, pp. 185–192, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- S. M. Domchek, T. M. Friebel, S. L. Neuhausen et al., “Mortality after bilateral salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers: a prospective cohort study,” The Lancet Oncology, vol. 7, no. 3, pp. 223–229, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- T. J. Colgan, J. Murphy, D. E. C. Cole, S. Narod, and B. Rosen, “Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status,” American Journal of Surgical Pathology, vol. 25, no. 10, pp. 1283–1289, 2001. View at Publisher · View at Google Scholar · View at Scopus
- N. D. Kauff, J. M. Satagopan, M. E. Robson et al., “Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation,” The New England Journal of Medicine, vol. 346, no. 21, pp. 1609–1615, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- K. Leeper, R. Garcia, E. Swisher, B. Goff, B. Greer, and P. Paley, “Pathologic findings in prophylactic oophorectomy specimens in high-risk women,” Gynecologic Oncology, vol. 87, no. 1, pp. 52–56, 2002. View at Publisher · View at Google Scholar · View at Scopus
- R. I. Olivier, M. Van Beurden, M. A. C. Lubsen et al., “Clinical outcome of prophylactic oophorectomy in BRCA1/BRCA2 mutation carriers and events during follow-up,” British Journal of Cancer, vol. 90, no. 8, pp. 1492–1497, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- B. C. Powell, E. Kenley, L. M. Chen et al., “Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy,” Journal of Clinical Oncology, vol. 23, no. 1, pp. 127–132, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- P. A. M. Meeuwissen, C. Seynaeve, C. T. M. Brekelmans, H. J. Meijers-Heijboer, J. G. M. Klijn, and C. W. Burger, “Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer,” Gynecologic Oncology, vol. 97, no. 2, pp. 476–482, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- A. Finch, P. Shaw, B. Rosen, J. Murphy, S. A. Narod, and T. J. Colgan, “Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers,” Gynecologic Oncology, vol. 100, no. 1, pp. 58–64, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. D. Lamb, R. L. Garcia, B. A. Goff, P. J. Paley, and E. M. Swisher, “Predictors of occult neoplasia in women undergoing risk-reducing salpingo-oophorectomy,” American Journal of Obstetrics and Gynecology, vol. 194, no. 6, pp. 1702–1709, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- M. J. Callahan, C. P. Crum, F. Medeiros et al., “Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction,” Journal of Clinical Oncology, vol. 25, no. 25, pp. 3985–3990, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- B. B. J. Hermsen, P. J. Van Diest, J. Berkhof et al., “Low prevalence of (pre) malignant lesions in the breast and high prevalence in the ovary and fallopian tube in women at hereditary high risk of breast and ovarian cancer,” International Journal of Cancer, vol. 119, no. 6, pp. 1412–1418, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- F. Medeiros, M. G. Muto, Y. Lee et al., “The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome,” American Journal of Surgical Pathology, vol. 30, no. 2, pp. 230–236, 2006. View at Publisher · View at Google Scholar
- E. Jarboe, A. Folkins, M. R. Nucci et al., “Serous carcinogenesis in the fallopian tube: a descriptive classification,” International Journal of Gynecological Pathology, vol. 27, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at PubMed
- D. W. Kindelberger, Y. Lee, A. Miron et al., “Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: evidence for a causal relationship,” American Journal of Surgical Pathology, vol. 31, no. 2, pp. 161–169, 2007. View at Publisher · View at Google Scholar · View at PubMed
- S. Salvador, A. Rempel, R. A. Soslow, B. Gilks, D. Huntsman, and D. Miller, “Chromosomal instability in fallopian tube precursor lesions of serous carcinoma and frequent monoclonality of synchronous ovarian and fallopian tube mucosal serous carcinoma,” Gynecologic Oncology, vol. 110, no. 3, pp. 408–417, 2008. View at Publisher · View at Google Scholar · View at PubMed
- J. W. Carlson, A. Miron, E. A. Jarboe et al., “Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention,” Journal of Clinical Oncology, vol. 26, no. 25, pp. 4160–4165, 2008. View at Publisher · View at Google Scholar · View at PubMed
- M. Hendrickson, J. Ross, A. Martinez et al., “Uterine papillary serous carcinoma. A highly malignant form of endometrial adenocarcinoma,” American Journal of Surgical Pathology, vol. 6, no. 2, pp. 93–108, 1982. View at Google Scholar · View at Scopus
- M. E. Sherman, P. Bitterman, N. B. Rosenshein, G. Delgado, and R. J. Kurman, “Uterine serous carcinoma: a morphologically diverse neoplasm with unifying clinicopathologic features,” American Journal of Surgical Pathology, vol. 16, no. 6, pp. 600–610, 1992. View at Google Scholar · View at Scopus
- J. V. Bokhman, “Two pathogenetic types of endometrial carcinoma,” Gynecologic Oncology, vol. 15, no. 1, pp. 10–17, 1983. View at Google Scholar · View at Scopus
- M. E. Sherman, M. E. Bur, and R. J. Kurman, “p53 In endometrial cancer and its putative precursors: evidence for diverse pathways of tumorigenesis,” Human Pathology, vol. 26, no. 11, pp. 1268–1274, 1995. View at Google Scholar · View at Scopus
- R. A. Ambros, M. E. Sherman, C. M. Zahn, P. Bitterman, and R. J. Kurman, “Endometrial intraepithelial carcinoma: a distinctive lesion specifically associated with tumors displaying serous differentiation,” Human Pathology, vol. 26, no. 11, pp. 1260–1267, 1995. View at Google Scholar · View at Scopus
- H. Tashiro, C. Isacson, R. Levine, R. J. Kurman, K. R. Cho, and L. Hedrick, “p53 gene mutations are common in uterine serous carcinoma and occur early in their pathogenesis,” American Journal of Pathology, vol. 150, no. 1, pp. 177–185, 1997. View at Google Scholar · View at Scopus
- E. A. Jarboe, A. Miron, J. W. Carlson et al., “Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance,” International Journal of Gynecological Pathology, vol. 28, no. 4, pp. 308–315, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- C. P. Crum, “Intercepting pelvic cancer in the distal fallopian tube: theories and realities,” Molecular Oncology, vol. 3, no. 2, pp. 165–170, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- Y. Lee, A. Miron, R. Drapkin et al., “A candidate precursor to serous carcinoma that originates in the distal fallopian tube,” Journal of Pathology, vol. 211, no. 1, pp. 26–35, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- A. K. Folkins, E. A. Jarboe, A. Saleemuddin et al., “A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations,” Gynecologic Oncology, vol. 109, no. 2, pp. 168–173, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- A. A. Tone, H. Begley, M. Sharma et al., “Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma,” Clinical Cancer Research, vol. 14, no. 13, pp. 4067–4078, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. Deheuninck and K. Luo, “Ski and SnoN, potent negative regulators of TGF- signaling,” Cell Research, vol. 19, no. 1, pp. 47–57, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- D. H. Yang, Z. Fazili, E. R. Smith et al., “Disabled-2 heterozygous mice are predisposed to endometrial and ovarian tumorigenesis and exhibit sex-biased embryonic lethality in a p53-null background,” American Journal of Pathology, vol. 169, no. 1, pp. 258–267, 2006. View at Publisher · View at Google Scholar · View at Scopus
- H. A. Risch, N. S. Weiss, J. L. Lyon et al., “Events of reproductive life and the incidence of epithelial ovarian cancer,” American Journal of Epidemiology, vol. 117, no. 2, pp. 128–139, 1983. View at Google Scholar · View at Scopus
- V. Beral, “Ovarian cancer and hormone replacement therapy in the Million Women Study,” The Lancet, vol. 369, no. 9574, pp. 1703–1710, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- J. Permuth-Wey and T. A. Sellers, “Epidemiology of ovarian cancer,” Methods in Molecular Biology, vol. 472, pp. 413–437, 2009. View at Publisher · View at Google Scholar · View at Scopus
- J. M. Schildkraut, E. Bastos, and A. Berchuck, “Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer,” Journal of the National Cancer Institute, vol. 89, no. 13, pp. 932–938, 1997. View at Google Scholar · View at Scopus
- J. M. Schildkraut, B. Calingaert, P. A. Marchbanks, P. G. Moorman, and G. C. Rodriguez, “Impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk,” Journal of the National Cancer Institute, vol. 94, no. 1, pp. 32–38, 2002. View at Google Scholar · View at Scopus
- P. M. Webb, A. Green, M. C. Cummings, D. M. Purdie, M. D. Walsh, and G. Chenevix-Trench, “Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer,” Journal of the National Cancer Institute, vol. 90, no. 22, pp. 1729–1734, 1998. View at Google Scholar · View at Scopus
- A. Saleemuddin, A. K. Folkins, L. Garrett et al., “Risk factors for a serous cancer precursor (“p53 signature”) in women with inherited BRCA mutations,” Gynecologic Oncology, vol. 111, no. 2, pp. 226–232, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- K. Q. Cai, A. Klein-Szanto, D. Karthik et al., “Age-dependent morphological alterations of human ovaries from populations with and without BRCA mutations,” Gynecologic Oncology, vol. 103, no. 2, pp. 719–728, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
- B. A. Werness, A. M. Afify, K. L. Bielat, G. H. Eltabbakh, M. S. Piver, and J. M. Paterson, “Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer,” Human Pathology, vol. 30, no. 2, pp. 151–157, 1999. View at Publisher · View at Google Scholar · View at Scopus
- R. R. Barakat, M. G. Federici, P. E. Saigo, M. E. Robson, K. Offit, and J. Boyd, “Absence of premalignant histologic, molecular, or cell biologic alterations in prophylactic oophorectomy specimens from BRCA1 heterozygotes,” Cancer, vol. 89, no. 2, pp. 383–390, 2000. View at Publisher · View at Google Scholar · View at Scopus
- A. K. Folkins, A. Saleemuddin, L. A. Garrett et al., “Epidemiologic correlates of ovarian cortical inclusion cysts (CICs) support a dual precursor pathway to pelvic epithelial cancer,” Gynecologic Oncology, vol. 115, no. 1, pp. 108–111, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus